Dennis Michael Styne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dennis Michael Styne has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Marilyn S. Townsend
Department of Nutrition, University of California, Davis, CA 95616, USA
2 shared publications - Anna-Barbara Moscicki
Department of Pediatrics, University of California, Los Angeles
1 shared publication - Byung-Kwang Yoo
Faculty of Human Sciences, School of Human Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa City, Saitama 359-1192, Japan
1 shared publication Christiana Drake
Department of Statistics, University of California at Davis, Davis, CA
1 shared publication- Christiana Drake
Department of Statistics, University of California, Davis, CA 95616, USA
1 shared publication - Christopher Ferber
Department of Medicine, Data Management and Statistical Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
1 shared publication
Latest Publications
- Open Access
The Dangers of Congregate for Children with Diabetes or Other Life-Threatening Medical Conditions
Background: Children can be removed from their home if allegations of abuse or neglect are substantiated. The preference is to place them with family members. In the most extreme cases, a child may be placed in a congregate care setting. A child with diabetes should only be placed in such a facility if the staff have been appropriately trained. Otherwise, the consequences can be devastating. In 2022 and 2024, two children were placed into congregate care facilities in Arizona and died of diabetic ketoacidosis due to a lack of appropriate employee training. Study Objective: We aim to inform providers of the legal processes and laws that can result in a child being placed into a congregate care setting. We analyze what went wrong in the care of these two children. We present alternative pathways that might ensure the safety of children before they are placed in such facilities. Methodology: We reviewed public information for cases of morbidity and mortality in children with diabetes in congregate care. We reviewed the California Welfare and Institution legal codes and applicable laws in the Federal Register. We obtained information regarding children with diabetes mellitus who were in the care of child welfare on PubMed. Results and Conclusions: While there are legal safeguards for children with diabetes who are placed in congregate care, these safeguards are ineffective if staff are inappropriately trained. We present programs and recommendations to prevent a child who is placed in a congregate care facility from suffering medical complications or death.
Open AccessThe Dangers of Congregate for Children with Diabetes or Other Life-Threatening Medical Conditions
Background: Children can be removed from their home if allegations of abuse or neglect are substantiated. The preference is to place them with family members. In the most extreme cases, a child may be placed in a congregate care setting. A child with diabetes should only be placed in such a facility if the staff have been appropriately trained. Otherwise, the consequences can be devastating. In 2022 and 2024, two children were placed into congregate care facilities in Arizona and died of diabetic ketoacidosis due to a lack of appropriate employee training. Study Objective: We aim to inform providers of the legal processes and laws that can result in a child being placed into a congregate care setting. We analyze what went wrong in the care of these two children. We present alternative pathways that might ensure the safety of children before they are placed in such facilities. Methodology: We reviewed public information for cases of morbidity and mortality in children with diabetes in congregate care. We reviewed the California Welfare and Institution legal codes and applicable laws in the Federal Register. We obtained information regarding children with diabetes mellitus who were in the care of child welfare on PubMed. Results and Conclusions: While there are legal safeguards for children with diabetes who are placed in congregate care, these safeguards are ineffective if staff are inappropriately trained. We present programs and recommendations to prevent a child who is placed in a congregate care facility from suffering medical complications or death.
- Open Access
- 3 June 2025
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 10 (1) , e70380
Correlation Between Technology and Improved Outcomes in Youth With Type 1 Diabetes Mellitus: Prospective Study Examining Outcomes for Patients With Depression and Those With Public Insurance
Background: Adherence to type 1 diabetes mellitus (T1DM) treatment regimens decreases during adolescence. While comorbid depression and health insurance disparities are individually known to potentiate this risk, technological devices for T1DM appear to be protective. Objective: We examined whether technology use impacted the association between depression and poorer health outcomes in T1DM. Given established insurance-based disparities based on technology access, we also studied whether the protective effects of T1DM technology differed among publicly and privately insured youth. Methods: Data were prospectively collected from pediatric patients with T1DM across 3 California medical centers. We used linear and negative binomial regression analyses to examine whether technology use was related to diabetes outcomes and whether this differed based on depression status (technology-by-depression interaction) and health insurance type (technology-by-insurance interaction). Results: Across 1573 patients aged 12 to 25 years (mean age 15.9, SD 2.9 years; n=1050, 66.4%, non-Hispanic White; n=745, 47.0% female), those with a depression diagnosis had higher hemoglobin A1c (HbA1c; mean 9.1%, SD 2.1% vs 10.1%, SD 2.2%) and more frequent diabetic ketoacidosis (DKA) events per year (mean 0.10, SD 0.36 vs 0.24, SD 0.66) than those without (P=.003). Patients using both a continuous glucose monitor (CGM) and pump had lower HbA1c levels and fewer DKA events per year (mean HbA1c 8.2%, SE 0.1%; mean DKA events per year 0.05, SE 0.01) than those using one device (mean HbA1c 9.0%, SE 0.1%; mean DKA events 0.08, SE 0.1%) or none (mean HbA1c 10.0%, SE 0.1%; mean DKA events 0.19, SE 0.1%; P<.001). While youth with public insurance had significantly higher HbA1c levels than those with commercial insurance (mean 9.3%, SD 2.1% vs 9.0%, SD 2.0%, P<.001), those using a CGM had no reliable decrease in HbA1c compared to their commercially insured peers (P=.35). Conclusions: Technology use in pediatric T1DM appears protective for both youth with a history of depression and those who are publicly insured. These data underscore the importance of universal access to technology to mitigate disparities based on comorbid mental health issues and differential access to care.
- 3 June 2025
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 10 (1) , e70380
Open AccessCorrelation Between Technology and Improved Outcomes in Youth With Type 1 Diabetes Mellitus: Prospective Study Examining Outcomes for Patients With Depression and Those With Public Insurance
Background: Adherence to type 1 diabetes mellitus (T1DM) treatment regimens decreases during adolescence. While comorbid depression and health insurance disparities are individually known to potentiate this risk, technological devices for T1DM appear to be protective. Objective: We examined whether technology use impacted the association between depression and poorer health outcomes in T1DM. Given established insurance-based disparities based on technology access, we also studied whether the protective effects of T1DM technology differed among publicly and privately insured youth. Methods: Data were prospectively collected from pediatric patients with T1DM across 3 California medical centers. We used linear and negative binomial regression analyses to examine whether technology use was related to diabetes outcomes and whether this differed based on depression status (technology-by-depression interaction) and health insurance type (technology-by-insurance interaction). Results: Across 1573 patients aged 12 to 25 years (mean age 15.9, SD 2.9 years; n=1050, 66.4%, non-Hispanic White; n=745, 47.0% female), those with a depression diagnosis had higher hemoglobin A1c (HbA1c; mean 9.1%, SD 2.1% vs 10.1%, SD 2.2%) and more frequent diabetic ketoacidosis (DKA) events per year (mean 0.10, SD 0.36 vs 0.24, SD 0.66) than those without (P=.003). Patients using both a continuous glucose monitor (CGM) and pump had lower HbA1c levels and fewer DKA events per year (mean HbA1c 8.2%, SE 0.1%; mean DKA events per year 0.05, SE 0.01) than those using one device (mean HbA1c 9.0%, SE 0.1%; mean DKA events 0.08, SE 0.1%) or none (mean HbA1c 10.0%, SE 0.1%; mean DKA events 0.19, SE 0.1%; P<.001). While youth with public insurance had significantly higher HbA1c levels than those with commercial insurance (mean 9.3%, SD 2.1% vs 9.0%, SD 2.0%, P<.001), those using a CGM had no reliable decrease in HbA1c compared to their commercially insured peers (P=.35). Conclusions: Technology use in pediatric T1DM appears protective for both youth with a history of depression and those who are publicly insured. These data underscore the importance of universal access to technology to mitigate disparities based on comorbid mental health issues and differential access to care.
- 21 April 2023
- Published by Springer Nature
- p. 301-340
Disorders of the Adrenal Gland
- 21 April 2023
- Published by Springer Nature
- p. 121-161
Disorders of the Thyroid Gland
- 21 April 2023
- Published by Springer Nature
- p. 35-54
The Posterior Pituitary Gland and Disorders of Vasopressin Metabolism
- 21 April 2023
- Published by Springer Nature
- p. 35-54
The Posterior Pituitary Gland and Disorders of Vasopressin Metabolism
- 21 April 2023
- Published by Springer Nature
- p. 1-13
Introduction to Pediatric Endocrinology: The Endocrine System
- 21 April 2023
- Published by Springer Nature
- p. 1-13
Introduction to Pediatric Endocrinology: The Endocrine System
- 21 April 2023
- Published by Springer Nature
- p. 497-506
Medications for Pediatric Endocrinology
- 21 April 2023
- Published by Springer Nature
- p. 203-239
Differences (Disorders) of Sexual Development (Differentiation)
- 21 April 2023
- Published by Springer Nature
- p. 203-239
Differences (Disorders) of Sexual Development (Differentiation)
- 21 April 2023
- Published by Springer Nature
- p. 421-477
Obesity
- 21 April 2023
- Published by Springer Nature
- p. 479-495
Pediatric Endocrine Emergencies